ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för apixaban. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

20 träffar

Bibliografisk träff 2013-02-01

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.

Frost C, Wang J, Nepal S, Schuster A, Barrett YC, Mosqueda-Garcia R, Reeves RA, LaCreta F.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/j.1365-2125.2012.04369.x

Bibliografisk träff 2013-02-01

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet · review; journal article · DOI 10.1007/s40262-012-0030-9

Bibliografisk träff 2013-02-01

Implications of new anticoagulants in primary practice.

Perez A, Eraso LH, Merli GJ.

Int J Clin Pract · research support, non-u.s. gov't; review; journal article · DOI 10.1111/ijcp.12023

Bibliografisk träff 2013-01-24

Clinical trials with new oral anticoagulants. Additive value of indirect comparisons also named network meta-analyses.

Harenberg J, Weiss C.

Hamostaseologie · review; journal article · DOI 10.5482/hamo-12-11-0021

Bibliografisk träff 2013-01-23

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg · meta-analysis; systematic review; journal article · DOI 10.1016/j.avsg.2012.06.010

Bibliografisk träff 2013-01-22

Pulmonary embolism hotline 2012. Recent and expected trials.

Konstantinides S, Lankeit M.

Hamostaseologie · review; journal article · DOI 10.5482/hamo-12-12-0024

Bibliografisk träff 2013-01-09

[Anticoagulation of older patients: what is new?].

Lafuente-Lafuente C, Pautas É, Belmin J.

Presse Med · review; evaluation study; journal article · DOI 10.1016/j.lpm.2012.05.031

Bibliografisk träff 2013-01-01

New oral therapies for the prevention and treatment of venous thromboembolism.

Hellwig T, Gulseth M.

Am J Health Syst Pharm · research support, non-u.s. gov't; review; journal article · DOI 10.2146/ajhp110601

Bibliografisk träff 2013-01-01

Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?

Strain J, Templeton K.

S D Med · journal article

Bibliografisk träff 2012-12-06

Low-dose anticoagulation for secondary prevention in acute coronary syndrome.

Verheugt FW.

Am J Cardiol · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.amjcard.2012.10.046

Bibliografisk träff 2012-12-05

New avenues for anticoagulation in atrial fibrillation.

Mantha S, Cabral K, Ansell J.

Clin Pharmacol Ther · review; journal article · DOI 10.1038/clpt.2012.197

Bibliografisk träff 2012-11-22

Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.

Pisters R, Nieuwlaat R, Lane DA, Crijns HJ, Lip GY.

Thromb Haemost · journal article · DOI 10.1160/th12-08-0539

Bibliografisk träff 2012-10-05

The laboratory and the new oral anticoagulants.

Tripodi A.

Clin Chem · review; journal article · DOI 10.1373/clinchem.2012.189704

Bibliografisk träff 2012-10-02

Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.

Flaker GC, Eikelboom JW, Shestakovska O, Connolly SJ, Kaatz S, Budaj A, Husted S, Yusuf S, Lip GY, Hart RG.

Stroke · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1161/strokeaha.112.664144

Bibliografisk träff 2012-06-01

Apixaban: a new player in the anticoagulant class.

Agrawal R, Jain P, Dikshit SN.

Curr Drug Targets · comparative study; review; journal article · DOI 10.2174/138945012800564059

Bibliografisk träff 2012-06-01

Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.

Deeks ED.

Drugs · review; journal article · DOI 10.2165/11209020-000000000-00000

Bibliografisk träff 2012-03-08

A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects.

Barrett YC, Wang J, Song Y, Pursley J, Wastall P, Wright R, Lacreta F, Frost C.

Thromb Haemost · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1160/th11-09-0634

Bibliografisk träff 2011-10-01

Apixaban: first global approval.

Watson J, Whiteside G, Perry C.

Drugs · journal article · DOI 10.2165/11596820-000000000-00000

Bibliografisk träff 2011-09-27

The role of apixaban for venous and arterial thromboembolic disease.

Prom R, Spinler SA.

Ann Pharmacother · review; journal article · DOI 10.1345/aph.1q119

Bibliografisk träff 2011-05-01

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor.

Wong PC, Pinto DJ, Zhang D.

J Thromb Thrombolysis · historical article; research support, non-u.s. gov't; research-article; review; journal article · DOI 10.1007/s11239-011-0551-3